MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.
Your Unread Messages in Psychiatry
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pharmacologic Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Depression increases risk of stroke in women
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
721 A multicentre randomized trial of combined individual and telephone counselling for smoking cessation Preventive Medicine, June 4, 2013 Clinical Article
722 The association between physical fitness and depressive symptoms among young adults: results of the Northern Finland 1966 birth cohort study Full Text BMC Public Health, June 4, 2013 Clinical Article
723 Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities Brain, Behavior, and Immunity, June 4, 2013 Clinical Article
724 Epidemiology of alcohol and drug use in the elderly Current Opinion in Psychiatry, June 4, 2013 Review Article
725 Do former substance users with psychosis differ in their symptoms or function from non-substance users? A systematic meta-analysis Australian and New Zealand Journal of Psychiatry, June 4, 2013 Evidence Based Medicine Review Article
726 Confirmatory factor analysis of the behavior rating inventory of executive function-adult version in healthy adults and application to attention-deficit/hyperactivity disorder Archives of Clinical Neurospsychology, June 4, 2013 Clinical Article
727 Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital International Journal of Psychiatry in Clinical Practice, June 4, 2013 Clinical Article
728 Educators views of eating disorder prevention programs Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, June 4, 2013 Review Article
729 Malingering and PTSD: detecting malingering and war related PTSD by miller forensic assessment of symptoms test (M-FAST) Full Text BMC Psychiatry, June 4, 2013 Clinical Article
730 Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development Progress in Neuro-Psychopharmacology and Biological Psychiatry, June 4, 2013 Clinical Article
731 Validation of a functional remission threshold for the functional remission of general schizophrenia (FROGS) scale Comprehensive Psychiatry, June 4, 2013 Clinical Article
732 The full spectrum of ethical issues in dementia care: systematic qualitative review The British Journal of Psychiatry, June 4, 2013 Evidence Based Medicine Review Article
733 Depressive symptoms enhance stress-induced inflammatory responses Brain, Behavior, and Immunity, June 4, 2013 Review Article
734 The correlation between emotional distress and aging males’ symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men Full Text Clinical Interventions in Aging, June 4, 2013 Review Article
735 Decreased cortical representation of genital somatosensory field after childhood sexual abuse American Journal of Psychiatry, June 4, 2013 Clinical Article
736 MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors Biological Psychiatry, June 4, 2013 Clinical Article
737 The impact of psychological factors on outcomes for spinal cord stimulation: an analysis with long-term follow-up Full Text Pain Physician, June 4, 2013 Clinical Article
738 The social cognition psychometric evaluation study: results of the expert survey and rand panel Schizophrenia Bulletin, June 4, 2013 Clinical Article
739 Changes in capacity to consent over time in patients involved in psychiatric research The British Journal of Psychiatry, June 4, 2013 Clinical Article
740 Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: randomised controlled trial The British Journal of Psychiatry, June 4, 2013 Clinical Article
As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).
Read the article summaryAs published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).
Read the article summaryAs published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).
Read the article summary1 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013
2 Evidence-Based Recommendations for the Prescription of Exercise for Major Depressive Disorder Journal of Psychiatric Practice, May 10, 2013 Evidence Based Medicine Review Article
3 The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study The Journal of Neuropsychiatry & Clinical Neurosciences, May 21, 2013
4 Vitamin D and depression in geriatric primary care patients Clinical Interventions in Aging, May 7, 2013 Free full text
5 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013 Evidence Based Medicine
6 Laser acupuncture for depression: A randomised double blind controlled trial using low intensity laser intervention Journal of Affective Disorders, May 14, 2013
7 Open-label pilot study on vitamin D3 supplementation for antipsychotic-associated metabolic anomalies International Clinical Psychopharmacology, May 22, 2013
8 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013
9 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 9, 2013
10 Meta-analysis: Aerobic exercise for the treatment of anxiety disorders Progress in Neuro-Psychopharmacology and Biological Psychiatry, May 28, 2013 Evidence Based Medicine Review Article
11 The effect of qigong on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials Evidence-based Complementary and Alternative Medicine , May 24, 2013 Free full text Evidence Based Medicine Review Article
12 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013
13 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013 Free full text
14 A double-blind trial of the effect of docosahexaenoic acid and vitamin and mineral supplementation on aggression, impulsivity, and stress Human Psychopharmacology: Clinical and Experimental, April 30, 2013
15 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013
16 Maternal depression, antidepressant use in pregnancy and Apgar scores in infants The British Journal of Psychiatry, May 2, 2013 Review Article
17 C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004 Journal of Behavioral Medicine, May 1, 2013 Review Article
18 A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep and exercise Journal of Affective Disorders, May 3, 2013 Review Article
19 Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial Journal of Affective Disorders, May 17, 2013
20 Cognitive Functioning in Patients Remitted from Recurrent Depression: Comparison with Acutely Depressed Patients and Controls and Follow-up of a Mindfulness-Based Cognitive Therapy Trial Cognitive Therapy and Research, May 13, 2013
Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close